These 2 Cheap Dividend Stocks Yield More Than 3% -- and They Beat the Market Last Year
It's OK to be greedy as an investor and want more than just a good dividend yield or solid growth. Some stocks actually offer both benefits, such as AbbVie (NYSE: ABBV) and ExxonMobil (NYSE: XOM). Plus, both stocks beat the market last year and yet are still trading cheaply. Here's why it may not be too late to invest in them right now.
Drugmaker AbbVie had a strong year in 2022, with its shares rising 19% -- a mirror image of the S&P 500's performance, which fell by a similar percentage. Strong and consistent results have made the healthcare stock a popular investment to hold over the past year.
In its most recent earnings report, the company reported net revenue of $14.8 billion, up 3.3% year over year, for the quarter ended Sept. 30, 2022. And if you exclude the impact of foreign exchange rates, then the growth rate is 5.4%. Up-and-coming immunology drugs Skyrizi and Rinvoq generated impressive growth of 75% and 54%, respectively.
Source Fool.com
